Crippling down factor IX for therapeutic gain
Journal of Thrombosis and Haemostasis, vol. 21, pp. 3287–3291
Authors 3
-
Viola J.F. Strijbis Aachen Department of Internal Medicine Division of Thrombosis and Hemostasis Einthoven Laboratory for Vascular and Regenerative Medicine
Leiden University · Leiden University Medical Center
Affiliation as printed
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: https://twitter.com/ViolaStrijbis
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands
-
Affiliation as printed
Department of Biology, Hakim Sabzevari University, Sabzevar, Iran
-
Mettine H.A. Bos corresponding Aachen Department of Internal Medicine Division of Thrombosis and Hemostasis Einthoven Laboratory for Vascular and Regenerative Medicine
Leiden University · Leiden University Medical Center
Affiliation as printed
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: M.H.A.Bos@lumc.nl
Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-11).